Skip to main content
. 2023 Aug 15;23:1549. doi: 10.1186/s12889-023-16418-9

Table 1.

Distribution of participant demographic, anthropometric, and cardiometabolic biomarkers by sex-specific waist-to-height ratio tertile categories

Variable Waist-to-Height Ratio
Male (n = 175) Female (n = 185)
T1 (n = 58) ≤ 0.55 T2 (n = 59) > 0.55- ≤ 0.59 T3 (n = 58) > 0.59 P-value T1 (n = 61) ≤ 0.56 T2 (n = 62) > 0.56- ≤ 0.6 T3 (n = 62) > 0.6 P Value
Age (years)a 9.2 (1.8) 9.2 (1.7) 9.3 (1.6) 0.95 9.0 (1.8) 9.5 (1.8) 9. 5 (1.7) 0.19
Race/ethnicity n (%)
Hispanic 45 (77.6) 44 (74.6) 43 (74.1) 44 (72.1) 47 (75.8) 44 (71.0) 0.78§
Non-Hispanic AA 8 (13.8) 11 (18.6) 10 (17.2) 0.96§ 11 (18.0) 9 (14.5) 14 (22.6)
Non-Hispanic White & Others 5 (8.6) 4 (6.8) 5 (8.6) 6 (9.8) 6 (9.7) 4 (6.5)
Parent education n (%)
 < High School 30 (51.7) 27 (45.8) 28 (48.3) 0.83§ 29 (47.5) 29 (46.8) 32 (51.6) 0.39§
High school or GED 13 (22.4) 17 (28.8) 18 (31.0) 15 (24.6) 21 (33.9) 12 (19.4)
 > High school 15 (25.9) 15 (25.4) 12 (20.7) 17 (27.9) 12 (19.4) 18 (29.0)
Parent occupation n (%)
Employed full time 9 (15.5) 10 (17.0) 10 (17.2) 1.00§ 11 (18.0) 13 (21.0) 16 (25.8) 0.46§
Employed part-time 10 (17.2) 9 (15.3) 9 (15.5) 7 (11.5) 13 (21.0) 9 (14.5)
Other (retired Homemaker unemployed) 39 (67.2) 40 (67.8) 39 (67.2) 43 (70.5) 36 (58.1) 37 (59.7)
Height (cm) a 140.6 (12.2) 139.2 (10.6) 141.8 (11.7) 0.50 138.6 (11.9) 142.2 (11.4) 142.2(11.5) 0.14
Weight (lbs) a 98.4 (23.9) 107.5 (26.1) 131.5 (35.0)  < .0001 95.5 (23.1) 113.1 (28.3) 134.0 (37.4)  < .0001
BMI Z scorea 1.7 (0.29) 2.1 (0.3) 2.4 (0.2)  < .0001 1.6 (0.3) 1.9 (0.3) 2.3 (0.2)  < .0001
SBP (mmHg) a 104.0 (7.5) 106.6 (9.3) 111.4 (11.8) 0.0002 102.2 (8.8) 106.3 (10.7) 109.5 (12.3) 0.001
DBP (mmHg)a 57.4 (5.2) 57. 7 (5.3) 59.8 (6.1) 0.05¥ 57.1 (4.8) 58.5 (6.1) 60.0 (5.6) 0.02
Triglycerides (mg/dL)b 63 (47–90) 73(49–101) 72(59–98) 0.16¥ 71 (52–113) 79(60–113) 86(61–126) 0.07¥
Total cholesterol (mg/dL)a 154.5 (27. 7) 153.5 (29.2) 159.5 (26.1) 0.46 157.6 (26.9) 151.3 (30.6) 158.1 (29. 4) 0.35
HDL-C (mg/dL)a 49.9 (10.2) 46.6 (7.9) 45.4 (9.2) 0.03 48.1 (9.8) 44.3 (9.0) 43.3 (9.7) 0.01
LDL-C (mg/dL)a 90.5 (23.1) 91.4 (25.1) 97.0 (20.4) 0.26 93.3 (23.2) 91.2 (20.7) 93.6 (25.5) 0.83
Fasting glucose (mg/dL)a 84.6 (7.1) 86.2 (7.1) 86.0 (10.5) 0.55 84.0 (8.1) 84. 6 (13.4) 84.6 (7.4) 0.93
Glucose 2 HR (mg/dL)a 93.3 (13. 7) 96.7 (15.0) 105. 8 (18.6) 0.0001 92.30 (16.4) 95.2 (20. 0) 100.9 (17.5) 0.03
Fasting insulin (μU/mL)b 10.3 (7.0–15.5) 12.5(9.9–18.2) 16.5 (11.6–23.4) 0.0001¥ 11.8 (8.2–16.5) 18.0 (11.5–28.0) 18.2(13.0–27.9)  < .0001¥
Fasting Insulin 2 HR (μU/mL)b 49.3 (26.3–72.1) 47.0 (27.5–74.1) 76.7(49.2–135.0) 0.0003¥ 46.9 (34.3–77.5) 92.9(63.8–157.1) 99.9(44.7–204.1)  < .0001¥
HOMA-IRb 2.0 (1.40–3.37) 2.5 (2.2–4.0) 3.5(2.3–5.3) 0.0002¥ 2.3 (1.5–3.4) 3.8 (2.5–5.9) 3.9 (2.6–6.1)  < .0001¥
ALT (SGPT) (µkat/L) 21 (19–28) 24 (19–29) 27(20–35) 0.03¥ 20 (17–24) 22(18–25) 22(18–29) 0.08¥
AST (SGOT) (μkat/L)b 31 (26–35) 32(27–35) 32(26–36) 0.82¥ 30 (27–34) 27(25–33) 28(25–32) 0.10¥
Tanner Stageb 1 (1–2) 1 (1–2) 1 (1–2) 0.84¥ 1(1–2) 2 (1–2) 2(1–2) 0.06¥

Analysis of Variance

§Pearson Chi-square test

¥Kruskal Wallis Test

a values are mean (SD)

bvalues are median (IQR)